Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02631902
Other study ID # UTras
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2015
Est. completion date December 2018

Study information

Verified date August 2019
Source University of Trás-os-Montes and Alto Douro
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Type 2 diabetes is a chronic disease that affects approximately 13% of Portuguese population and is associated with a high cardiovascular mortality by coronary artery disease and cerebrovascular disease and with a serious decline on well-being. Lifestyle changes are widely recommended to the control of type 2 diabetes and its complications. This study aims to analyse the effects of different community-based lifestyle programs (exercise or exercise plus dietary intervention) on health and well-being in patients with type 2 diabetes.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date December 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 50 Years to 80 Years
Eligibility Inclusion Criteria:

1. Patients with diagnosed type 2 diabetes at least for six months;

2. Both genders;

3. Aged between 50 and 80 years old;

4. Non-smokers;

5. Not engaged in supervised exercise;

6. Community-dwelling;

7. Medical recommendation for lifestyle intervention;

8. Known medical history;

9. Diabetes complications under medical control (poor metabolic control, diabetic foot, diabetic retinopathy, diabetic nephropathy and diabetic autonomic neuropathy;

10. No cardiovascular, respiratory and musculoskeletal contraindications to exercise;

11. No gait and balance problems;

12. Not taking insulin or sulfonylureas for less than three months;

13. Volunteer participation with signed informed consent.

Exclusion Criteria:

1. Participation in another supervised exercise program during the study;

2. Participation in another supervised dietary intervention during the study;

3. Aggravation of a diabetes complication or another major health problem;

Study Design


Intervention

Behavioral:
Exercise
Community-based exercise program with 3 weekly exercise sessions
Dietary intervention
Community-based dietary intervention program

Locations

Country Name City State
Portugal University of Trás-os-Montes e Alto Douro Vila Real

Sponsors (1)

Lead Sponsor Collaborator
University of Trás-os-Montes and Alto Douro

Country where clinical trial is conducted

Portugal, 

References & Publications (3)

Matos M, Mendes R, Silva AB, Sousa N. Physical activity and exercise on diabetic foot related outcomes: A systematic review. Diabetes Res Clin Pract. 2018 May;139:81-90. doi: 10.1016/j.diabres.2018.02.020. Epub 2018 Feb 23. Review. — View Citation

Vasconcelos C, Almeida A, Cabral M, Ramos E, Mendes R. The Impact of a Community-Based Food Education Program on Nutrition-Related Knowledge in Middle-Aged and Older Patients with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial. Int J Envi — View Citation

Vasconcelos C, Almeida A, Sá C, Viana J, Cabral M, Ramos E, Mendes R. Nutrition-related knowledge and its determinants in middle-aged and older patients with type 2 diabetes. Prim Care Diabetes. 2019 Jul 23. pii: S1751-9918(18)30418-2. doi: 10.1016/j.pcd. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cardiovascular Risk UKPDS Risk Engine Baseline, 9 and 21 months
Primary Health-Related Quality of Life SF-36 Health Survey Baseline, 9 and 21 months
Secondary Food Literacy General Nutrition Knowledge Questionnaire for Adults Baseline, 9 and 21 months
Secondary Dietary Pattern 3-day Food Record Baseline, 9 and 21 months
Secondary Physical Fitness Physical Fitness Test Battery Baseline, 9 and 21 months
Secondary Diabetic Foot Risk International Working Group on the Diabetic Foot Risk Classification) Baseline, 9 and 21 months
Secondary Exercise-Related Adverse Events Number of acute injuries or adverse events during exercise sessions Baseline, 9 and 21 months
Secondary Systolic Blood Pressure mmHg Baseline, 9 and 21 months
Secondary Diastolic Blood Pressure mmHg Baseline, 9 and 21 months
Secondary Glycemic Control Glycated Hemoglobin Baseline, 9 and 21 months
Secondary Fast blood glucose mg/dL Baseline, 9 and 21 months
Secondary Total Cholesterol mg/dL Baseline, 9 and 21 months
Secondary Body Fat Mass Bioelectrical impedance analysis Baseline, 9 and 21 months
Secondary Body Lean Mass Bioelectrical impedance analysis Baseline, 9 and 21 months
Secondary Quality of Sleep Pittsburgh Sleep Quality Index Baseline, 9 and 21 months
Secondary Symptoms of Anxiety and Depression Hospital Anxiety and Depression Scale Baseline, 9 and 21 months
Secondary Chronic Pain Brief Pain Inventory Questionnaire Baseline, 9 and 21 months
Secondary Diabetes-Dependent Quality of Life Audit of Diabetes-Dependent Quality of Life Questionnaire Baseline, 9 and 21 months
Secondary Habitual Physical Activity International Physical Activity Questionnaire Baseline, 9 and 21 months
Secondary Waist Circumference cm Baseline, 9 and 21 months
Secondary Falls Risk Timed Up and Go Test Baseline, 9 and 21 months
Secondary Sitting-Time Hours per day Baseline, 9 and 21 months
Secondary Energy Expenditure kcal/kg/min Baseline, 9 and 21 months
Secondary Body Mass Index kg/m2 Baseline, 9 and 21 months
See also
  Status Clinical Trial Phase
Completed NCT02771093 - An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus Phase 4
Completed NCT02545842 - Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) Phase 4
Recruiting NCT03436212 - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. N/A
Completed NCT03244800 - A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Phase 2
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Withdrawn NCT02769091 - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes Phase 2
Recruiting NCT06065540 - A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Phase 3
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT04091373 - A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide Phase 1
Completed NCT03296800 - Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects Phase 1
Recruiting NCT06212778 - Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
Completed NCT05979519 - Fresh Carts for Mom's to Improve Food Security and Glucose Management N/A
Recruiting NCT05579314 - XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Terminated NCT03684642 - Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Phase 3
Completed NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Completed NCT03644134 - A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns N/A
Completed NCT05295160 - Fasting-Associated Immune-metabolic Remission of Diabetes N/A
Completed NCT02836873 - Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment Phase 3
Completed NCT02252224 - Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance

External Links